|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61K 31/4995 | |||
| C07D 401/12 | |||
| C07D 401/14 | |||
| C07D 413/14 | |||
| C07D 215/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 2658543 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11811286.1 |
| Date of filing the European patent application | 2011-12-29 | |
| (97) | Date of publication of the European application | 2013-11-06 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/067752 |
| Date | 2011-12-29 |
| (87) | Number | WO 2012/092442 |
| Date | 2012-07-05 |
| (30) | Number | Date | Country code |
| 201061428030 P | 2010-12-29 | US |
| (72) |
SALITURO, Francesco G., US
SAUNDERS, Jeffrey O., US
YAN, Shunqi, US
|
| (73) |
Agios Pharmaceuticals, Inc.,
88 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | PYRUVATE KINASE M2 (PKM2) ACTIVATORS FOR USE IN THERAPY |
| PYRUVATE KINASE M2 (PKM2) ACTIVATORS FOR USE IN THERAPY |